Cargando…
Anemia requiring transfusion in breast cancer patients on dose-dense chemotherapy: Prevalence, risk factors, cost and effect on disease outcome
PURPOSE: Dose-dense chemotherapy improves survival but with increased toxicity and treatment-related cost. We report the prevalence of anemia and the possible risk factors associated with chemotherapy-related anemia and determine the cost and time-delay associated with transfusion requirement in Ind...
Autores principales: | Sharma, Parth, Georgy, Josh Thomas, Andrews, Anand George, John, Ajoy Oommen, Joel, Anjana, Chacko, Raju Titus, Premkumar, Prasanna Samuel, Singh, Ashish |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8937495/ https://www.ncbi.nlm.nih.gov/pubmed/35314996 http://dx.doi.org/10.1007/s00520-022-06970-2 |
Ejemplares similares
-
Docetaxel, Oxaliplatin and Capecitabine (TEX) triplet regimen as adjuvant chemotherapy in resected gastric adenocarcinoma
por: Thumaty, Divya Bala, et al.
Publicado: (2021) -
End-of-Treatment FDG PET-CT (EOT-PET) in Patients with Post-Chemotherapy Masses for Seminoma: Can We Avoid Further Intervention?
por: Joel, Anjana, et al.
Publicado: (2022) -
Primary mediastinal germ cell tumours: real world experience in the low middle income (LMIC) setting
por: Joel, Anjana, et al.
Publicado: (2021) -
Neoadjuvant chemotherapy with biosimilar trastuzumab in human epidermal growth factor receptor 2 overexpressed non-metastatic breast cancer: patterns of use and clinical outcomes in India
por: Joel, Anjana, et al.
Publicado: (2021) -
CDK 4/6 inhibitor induced lung injury: a case report and review of literature
por: Mathew, Namrata, et al.
Publicado: (2021)